Introduction
- Second Generation Antipsychotics (SGAs) continue to drive the
antipsychotic market with a growth rate of 27.2% between 2002-2003, yielding
revenues of over $9.5 billion in 2003 responsible for a 93.3% share of the
market. However, several patent expiries and product launches are set to
send the market through a period of change.
Scope of this report
- Overview of current market including profiles of key brands and key events
impacting each brand during 2003-2004
- Assessment of current and future opportunities and threats in the
antipsychotics market across the seven major pharmaceutical markets
- Global sales for leading antipsychotic products from 1999-2003 are
presented, with projections for future performance up to 2014
- In-depth discussion of assumptions and events used in forecast analysis
Research and analysis highlights
- With an increasingly crowded schizophrenia market, SGA manufacturers are
seeking to add new indications to their products labeling, capitalizing on
the existing high off-label. Already, the majority of SGAs are approved for
bipolar mania, and many have or are in the process of gaining approval for
bipolar maintenance, as well as other niche areas.
- Zyprexa, the market leading SGA, is currently experiencing patent
challenges from numerous generics manufacturers. Datamonitor believes it is
likely that Lilly will prevail in the courts, although, if generic incursion
occurs in 2005, the SGA market could look very different.
- The extreme interest in this market place by generics manufacturers is
unsurprising. The SGA market currently includes three blockbuster brands
with Abilify joining this select club in 2005. Datamonitor forecasts that
three of the generic molecules will see blockbuster revenues by 2013.
Key reasons to read this report
- Quantify future size and scope of antipsychotics market and potential for
new products
- Understand key drivers to this market and predict future performance of
these compounds
- Identify hot areas of the market not targeted by competitors
View Cart
